21 CFR Part 870 - CARDIOVASCULAR DEVICES
- Subpart A - General Provisions (§§ 870.1 - 870.9)
- Subpart B - Cardiovascular Diagnostic Devices (§§ 870.1025 - 870.1915)
- Subpart C - Cardiovascular Monitoring Devices (§§ 870.2050 - 870.2920)
- Subpart D - Cardiovascular Prosthetic Devices (§§ 870.3250 - 870.3945)
- Subpart E - Cardiovascular Surgical Devices (§§ 870.4075 - 870.4885)
- Subpart F - Cardiovascular Therapeutic Devices (§§ 870.5050 - 870.5925)
Source:
45 FR 7907, Feb. 5, 1980, unless otherwise noted.
Editorial Note:
Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.
{'United States Code': [{'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '360', 'headtext': ' Registration of producers of drugs or devices', 'cleanpath': '/uscode/text/21/360'}, {'Title': '21', 'Section': '360c', 'headtext': ' Classification of devices intended for human use', 'cleanpath': '/uscode/text/21/360c'}, {'Title': '21', 'Section': '360e', 'headtext': ' Premarket approval', 'cleanpath': '/uscode/text/21/360e'}, {'Title': '21', 'Section': '360j', 'headtext': ' General provisions respecting control of devices intended for human use', 'cleanpath': '/uscode/text/21/360j'}, {'Title': '21', 'Section': '360l', 'headtext': ' Postmarket surveillance', 'cleanpath': '/uscode/text/21/360l'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}